Maxx Orthopedics Announces US FDA Approval of FreedomŽ Ultra-Congruent Liner Option Ahead of American Academy of Orthopaedic Surgeons (AAOS) Meeting

Friday, March 8, 2019 Press Release
Email Print This Page Comment bookmark
Font : A-A+

The FreedomŽ Ultra-Congruent Liner (UC) has received US FDA approval and is the latest tibial liner offering in the FreedomŽ Knee System. The UC liner's unique design was developed with the desire to achieve a higher level of constraint than typically achieved in a traditional cruciate-retaining (CR) knee design and offers new liner thicknesses to help better match The FreedomŽ Knee to the needs of the patient.

NORRISTOWN, Pa., March 7, 2019 /PRNewswire-PRWeb/ -- Maxx Orthopedics, Inc. a subsidiary of Maxx Medical, Pvt. Ltd.,

a rapidly expanding global orthopedics device company, today announced that it has received US FDA clearance for its FreedomŽ Ultra-Congruent liner, the latest addition to its Freedom KneeŽ System.

The FreedomŽ Ultra-Congruent Liner (UC) was developed with the desire to achieve a higher level of constraint than typically achieved in a traditional cruciate-retaining (CR) knee design. The UC tibial liner includes a deep anterior patellar cut-out to allow for tendon clearance, a prominent anterior lip that aids in prevention of anterior subluxation of the femur, and a prominent posterior lip that assists in resisting posterior translation of the femur. Providing patients with more precise balance and stability, the thickness offerings for the FreedomŽ Ultra-Congruent Liner will be 1mm increments throughout the size range.

"We are thrilled to add the UC liner offering to our FreedomŽ Knee System. In addition to the unique design of the Ultra-Congruent liner, we are also introducing new liner thicknesses to help our customers better match the Freedom Knee to the needs of the individual patient. This is an evolutionary step towards our goal of creating and providing solutions that best fit our patients' needs so they, along with our medical professionals, continue to have the best possible outcomes." said Ashesh Shah, CEO, Maxx Medical.

Launched in 2009, The Freedom KneeŽ System is a total knee replacement system specifically engineered for high flexion, bone conservation and advanced component size and fit capabilities. Maxx will be displaying The FreedomŽ Ultra-Congruent Liner at AAOS Annual Meeting, March 13-15, in Las Vegas, NV (Booth #2063). For additional information, please visit http://www.maxxortho.com.

About Maxx Medical Maxx Medical Pvt. Ltd. ("Maxx Medical") develops and markets innovative orthopedic medical devices on an international scale. The company is focused on providing state-of-the-art implants and related solutions that best restore patient mobility while accommodating lifestyle, anatomical and economic needs. Maxx Medical is the parent company of Maxx Orthopedics, Inc., the manufacturer of the Freedom KneeŽ System and LibertasŽ Total Hip System.

 

SOURCE Maxx Orthopedics



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store